Medix Biochemica appoints former Roche executive to its Board of Directors
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
She joins Enveda from Gilead Sciences
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
New Director supports NASDAQ rule on diversity
Subscribe To Our Newsletter & Stay Updated